April 26, 2024
by Andrii Buvailo, PhD
Interview
The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling …
April 18, 2024
by Andrii Buvailo, PhD
Interview
Sponsored by Trialize
In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …
April 12, 2024
by Andrii Buvailo, PhD
Interview
My interview with Mirit Eldor, Managing Director, Life Sciences Solutions, at Elsevier, as we discuss Elsevier's recent collaboration with gen …
Feb. 23, 2024
by Andrii Buvailo, PhD
Interview
In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
In this episode, I dive deep into the burgeoning digital health landscape of the United Arab Emirates, a region rapidly …
Jan. 23, 2024
by Andrii Buvailo
Interview
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
Jan. 11, 2024
by Andrii Buvailo
Interview
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Oct. 29, 2023
by Andrii Buvailo
Interview
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
Sept. 22, 2023
by Andrii Buvailo
Interview
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …
Sept. 13, 2023
by Andrii Buvailo
Interview
Biotechnology is more than just an emerging scientific frontier, it also impacts global economy, competition, and societal transformation. To learn …
Sept. 3, 2023
by Andrii Buvailo
Interview
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …